메뉴 건너뛰기




Volumn 19, Issue 1, 2009, Pages 1-8

Drug resistant MCF-7 cell lines also developed cross-resistance to structurally unrelated anticancer agents

Author keywords

Chemotherapy; Cross resistance; MCF 7; Multiple drug resistence

Indexed keywords

ANTINEOPLASTIC AGENT; DOCETAXEL; DOXORUBICIN; PACLITAXEL; RETINOIC ACID; TAMOXIFEN; VINCRISTINE;

EID: 67149133350     PISSN: 1306133X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (18)

References (36)
  • 1
    • 0031435837 scopus 로고    scopus 로고
    • Mechanisms of drug resistance in hematologic malignancies
    • Dalton WS. Mechanisms of drug resistance in hematologic malignancies. Semin Hematol 34: 3-8, 1997.
    • (1997) Semin Hematol , vol.34 , pp. 3-8
    • Dalton, W.S.1
  • 2
    • 0024360795 scopus 로고
    • P-glycoprotein and multidrug resistance in cancer chemotherapy
    • Deuchars KL, Ling V. P-glycoprotein and multidrug resistance in cancer chemotherapy. Semin Oncol 16: 156-165, 1989.
    • (1989) Semin Oncol , vol.16 , pp. 156-165
    • Deuchars, K.L.1    Ling, V.2
  • 3
    • 0345505691 scopus 로고    scopus 로고
    • The role of multidrug transporters in drug availability, metabolism and toxicity
    • Bodo A, Bakos E, Szeri F, et al. The role of multidrug transporters in drug availability, metabolism and toxicity. Toxicol Lett 140: 133-143, 2003.
    • (2003) Toxicol Lett , vol.140 , pp. 133-143
    • Bodo, A.1    Bakos, E.2    Szeri, F.3
  • 4
    • 1142291910 scopus 로고    scopus 로고
    • Drug resistance in breast cancer
    • Lage H. Drug resistance in breast cancer. Cancer Therapy 1: 81-91, 2003.
    • (2003) Cancer Therapy , vol.1 , pp. 81-91
    • Lage, H.1
  • 5
    • 12944277104 scopus 로고    scopus 로고
    • A common pharmacophore for epothilone and taxanes: Molecular basis of drug resistance conferred by tubulin mutations in human cancer cells
    • Giannakakau P, Gussio R, Nogales E, et al. A common pharmacophore for epothilone and taxanes: Molecular basis of drug resistance conferred by tubulin mutations in human cancer cells. Proc Nat Acad Sci USA 97: 2904-2909, 2000.
    • (2000) Proc Nat Acad Sci USA , vol.97 , pp. 2904-2909
    • Giannakakau, P.1    Gussio, R.2    Nogales, E.3
  • 6
    • 0034624329 scopus 로고    scopus 로고
    • Differential sensitivity of MCF-7 and LCC2 cells, to multiple growth inhibitory agents: Possible relation to high bcl-2/bax ratio?
    • Lilling G, Hacohen H, Nordenberg J, et al. Differential sensitivity of MCF-7 and LCC2 cells, to multiple growth inhibitory agents: Possible relation to high bcl-2/bax ratio? Cancer Lett 161: 27-34, 2000.
    • (2000) Cancer Lett , vol.161 , pp. 27-34
    • Lilling, G.1    Hacohen, H.2    Nordenberg, J.3
  • 7
    • 0042024879 scopus 로고    scopus 로고
    • An in vitro study to evaluate the synergistic activity of norfloxacin and metronidazole
    • Bharadwaj R, Vidya A, Dewan B, Pal A. An in vitro study to evaluate the synergistic activity of norfloxacin and metronidazole. Indian J Pharmacol 35: 220-226, 2003.
    • (2003) Indian J Pharmacol , vol.35 , pp. 220-226
    • Bharadwaj, R.1    Vidya, A.2    Dewan, B.3    Pal, A.4
  • 8
    • 0035197533 scopus 로고    scopus 로고
    • Combination chemotherapy of the taxanes and antimetabolites: Its use and limitations
    • Smorenburg CH, Sparreboom A, Bontenbal M, Verweij J. Combination chemotherapy of the taxanes and antimetabolites: Its use and limitations. Eur J Cancer 37: 2310-2323, 2001.
    • (2001) Eur J Cancer , vol.37 , pp. 2310-2323
    • Smorenburg, C.H.1    Sparreboom, A.2    Bontenbal, M.3    Verweij, J.4
  • 9
    • 27644497583 scopus 로고    scopus 로고
    • Weekly administration of docetaxel and paclitaxel in metastatic or advanced breast cancer
    • Enju A, Palmieri FM, Perez EA. Weekly administration of docetaxel and paclitaxel in metastatic or advanced breast cancer. Oncologist 10: 665-85, 2005.
    • (2005) Oncologist , vol.10 , pp. 665-685
    • Enju, A.1    Palmieri, F.M.2    Perez, E.A.3
  • 10
    • 0031409092 scopus 로고    scopus 로고
    • Clinical Oncology Update, Review of recent trials of chemotherapy for advanced breast cancer: The taxanes
    • Clemons M, Leahy M, Valle J, et al. Clinical Oncology Update, Review of recent trials of chemotherapy for advanced breast cancer: The taxanes. Eur J Cancer 33: 2183-93, 1997.
    • (1997) Eur J Cancer , vol.33 , pp. 2183-2193
    • Clemons, M.1    Leahy, M.2    Valle, J.3
  • 11
    • 0019805521 scopus 로고
    • Taxol-induced polymerization of purified tubulin: Mechanism of action
    • Kumar N. Taxol-induced polymerization of purified tubulin: Mechanism of action. J Biol Chem 256: 10435-41,1981.
    • (1981) J Biol Chem , vol.256 , pp. 10435-10441
    • Kumar, N.1
  • 12
    • 0036634786 scopus 로고    scopus 로고
    • Survival of docetaxel-resistant prostate cancer cells in vitro depends on phenotype alterations and continuity of drug exposure
    • Makarovskiy AN, Siryaporn E, Hixson DC, Akerley W. Survival of docetaxel-resistant prostate cancer cells in vitro depends on phenotype alterations and continuity of drug exposure. Cell Mol Life Sci 59: 1198-211, 2002.
    • (2002) Cell Mol Life Sci , vol.59 , pp. 1198-1211
    • Makarovskiy, A.N.1    Siryaporn, E.2    Hixson, D.C.3    Akerley, W.4
  • 13
    • 0029360519 scopus 로고
    • Microtubule dynamics: Taking aim at a moving target
    • Wilson L, Jordan MA. Microtubule dynamics: taking aim at a moving target. Chem Biol 2: 569-73, 1995.
    • (1995) Chem Biol , vol.2 , pp. 569-573
    • Wilson, L.1    Jordan, M.A.2
  • 14
    • 0025272246 scopus 로고
    • Topoietoposide, and cytarabine in patients with refractory and relapsed acute myelogenous leukemia (AML)
    • Zijlstra JG, deJong S, deVries EG, Mulder NH. Topoietoposide, and cytarabine in patients with refractory and relapsed acute myelogenous leukemia (AML). Tumor Pharmacother 7: 11-18, 1990.
    • (1990) Tumor Pharmacother , vol.7 , pp. 11-18
    • Zijlstra, J.G.1    deJong, S.2    deVries, E.G.3    Mulder, N.H.4
  • 15
    • 0025155529 scopus 로고
    • Epirubicincardio-toxicity: A studyof 135 patients with advanced breast cancer
    • Nielsen D, Jensen JB, Dombernowsky P. Epirubicincardio-toxicity: A studyof 135 patients with advanced breast cancer. J Clin Oncol 8: 1806-1810, 1990.
    • (1990) J Clin Oncol , vol.8 , pp. 1806-1810
    • Nielsen, D.1    Jensen, J.B.2    Dombernowsky, P.3
  • 16
    • 0031468368 scopus 로고    scopus 로고
    • Anthracyclines in haematology: During chemotherapy; preclinical studies, toxicity and delivery systems
    • Richardson DS, Johnson SA. Anthracyclines in haematology: during chemotherapy; preclinical studies, toxicity and delivery systems. Blood Rev 11: 201-223, 1997.
    • (1997) Blood Rev , vol.11 , pp. 201-223
    • Richardson, D.S.1    Johnson, S.A.2
  • 17
    • 0028234673 scopus 로고
    • Up-regulation of a mutant form of p53 by doxorubicin in human squamous carcinoma cells
    • Kwok TT, Mok CH, Menton-Brennan L. Up-regulation of a mutant form of p53 by doxorubicin in human squamous carcinoma cells. Cancer Res 54: 2834-36, 1994.
    • (1994) Cancer Res , vol.54 , pp. 2834-2836
    • Kwok, T.T.1    Mok, C.H.2    Menton-Brennan, L.3
  • 18
    • 0024312674 scopus 로고
    • Tamoxifen therapy in breast cancer: Biology, efficacy, and side effects
    • Love RR. Tamoxifen therapy in breast cancer: biology, efficacy, and side effects. J Clin Oncol 7: 803-15, 1989.
    • (1989) J Clin Oncol , vol.7 , pp. 803-815
    • Love, R.R.1
  • 19
    • 0030764346 scopus 로고    scopus 로고
    • Inhibition of trans-retinoic acid-resistant human breast cancer cell growth by retinoid X receptor-selective retinoids
    • Wu Q, Dawson MI, Zheng Y, et al. Inhibition of trans-retinoic acid-resistant human breast cancer cell growth by retinoid X receptor-selective retinoids. Mol Cell Biol 17: 6598-608, 1997.
    • (1997) Mol Cell Biol , vol.17 , pp. 6598-6608
    • Wu, Q.1    Dawson, M.I.2    Zheng, Y.3
  • 20
    • 33845936497 scopus 로고    scopus 로고
    • Development of Rational in-vitro Models for Drug Resistance in Breast Cancer and Modulation of MDR by Selected Compounds
    • Kars MD, Iseri ÖD, Gündüz U, et al. Development of Rational in-vitro Models for Drug Resistance in Breast Cancer and Modulation of MDR by Selected Compounds. Anticancer Res 26: 4559-68, 2006.
    • (2006) Anticancer Res , vol.26 , pp. 4559-4568
    • Kars, M.D.1    Iseri, O.D.I.E.D.2    Gündüz, U.3
  • 21
    • 37549029516 scopus 로고    scopus 로고
    • In Vitro evaluation of zoledronic acid resistance developed in MCF-7 cells
    • Kars MD, Iseri ÖD, Ural AU, Gündüz U. In Vitro evaluation of zoledronic acid resistance developed in MCF-7 cells. Anticancer Res 27: 4031-38, 2007.
    • (2007) Anticancer Res , vol.27 , pp. 4031-4038
    • Kars, M.D.1    Iseri, O.D.I.E.D.2    Ural, A.U.3    Gündüz, U.4
  • 23
    • 0344678381 scopus 로고    scopus 로고
    • Current options in treatment of anthracycline-resistant breast cancer
    • Kröger N, Achterrath W, Hegewisch-Becker S, et al. Current options in treatment of anthracycline-resistant breast cancer. Cancer Treat Rev 25: 279-291, 1999.
    • (1999) Cancer Treat Rev , vol.25 , pp. 279-291
    • Kröger, N.1    Achterrath, W.2    Hegewisch-Becker, S.3
  • 24
    • 21044456009 scopus 로고    scopus 로고
    • Efficacy of weekly paclitaxel in patients with docetaxel-resistant metastatic breast cancer
    • Yonemori K, Katsumata N, Uno H, et al. Efficacy of weekly paclitaxel in patients with docetaxel-resistant metastatic breast cancer. Breast Cancer Res Tr 89: 237-241, 2005.
    • (2005) Breast Cancer Res Tr , vol.89 , pp. 237-241
    • Yonemori, K.1    Katsumata, N.2    Uno, H.3
  • 25
    • 1842554867 scopus 로고    scopus 로고
    • Cross-resistance studies of isogenic drug-resistant breast tumor cell lines support recent clinical evidence suggesting that sensitivity to paclitaxel may be strongly compromised by prior doxorubicin exposure
    • Guo B, Villeneuve DJ, Hembruff SL, et al. Cross-resistance studies of isogenic drug-resistant breast tumor cell lines support recent clinical evidence suggesting that sensitivity to paclitaxel may be strongly compromised by prior doxorubicin exposure. Breast Cancer Res Tr 85: 31-51, 2004.
    • (2004) Breast Cancer Res Tr , vol.85 , pp. 31-51
    • Guo, B.1    Villeneuve, D.J.2    Hembruff, S.L.3
  • 26
    • 0031441798 scopus 로고    scopus 로고
    • Prospects with docetaxel in the treatment of patients with breast cancer
    • Marty M, Extra JM, Cottu PH, Espie M. Prospects with docetaxel in the treatment of patients with breast cancer. Eur J Cancer 33: 26-29, 1997.
    • (1997) Eur J Cancer , vol.33 , pp. 26-29
    • Marty, M.1    Extra, J.M.2    Cottu, P.H.3    Espie, M.4
  • 27
    • 35748948098 scopus 로고    scopus 로고
    • Overview and new strategies in metastatic breast cancer (MBC) for treatment of tamoxifen-resistant patients
    • Adamo V, Iorfida M, Montalto E, et al. Overview and new strategies in metastatic breast cancer (MBC) for treatment of tamoxifen-resistant patients. Ann Oncol 18: 53-57, 2007.
    • (2007) Ann Oncol , vol.18 , pp. 53-57
    • Adamo, V.1    Iorfida, M.2    Montalto, E.3
  • 28
    • 0031758794 scopus 로고    scopus 로고
    • A phase II study of docetaxel in patients with paclitaxel-resistant metastatic breast cancer
    • Valero V, Jones SE, Von Hoff DD, et al. A phase II study of docetaxel in patients with paclitaxel-resistant metastatic breast cancer. J Clin Oncol 16: 3362-8, 1998.
    • (1998) J Clin Oncol , vol.16 , pp. 3362-3368
    • Valero, V.1    Jones, S.E.2    Von Hoff, D.D.3
  • 29
    • 0037141341 scopus 로고    scopus 로고
    • Expression of multidrug resistance-associated protein1, Pglycoprotein, and thymidylate synthase in gastric cancer patients treated with 5-fluorouracil and doxorubicin-based adjuvant chemotherapy after curative resection
    • Choi H, Lim H-Y, Joo HJ, et al. Expression of multidrug resistance-associated protein1, Pglycoprotein, and thymidylate synthase in gastric cancer patients treated with 5-fluorouracil and doxorubicin-based adjuvant chemotherapy after curative resection. Brit J Cancer 86: 1578-85, 2002.
    • (2002) Brit J Cancer , vol.86 , pp. 1578-1585
    • Choi, H.1    Lim, H.-Y.2    Joo, H.J.3
  • 30
    • 0025821275 scopus 로고
    • Multidrug-resistant myeloma: Laboratory and clinical effects of verapamil as a chemosensitizer
    • Salmon SE, Dalton WS, Grogan TM, et al. Multidrug-resistant myeloma: Laboratory and clinical effects of verapamil as a chemosensitizer. Blood l78: 44-50, 1991.
    • (1991) Blood l78 , pp. 44-50
    • Salmon, S.E.1    Dalton, W.S.2    Grogan, T.M.3
  • 31
    • 0037981367 scopus 로고    scopus 로고
    • A mechanism of drug resistance to tamoxifen in breast cancer
    • Schafer JM, Bentrem DJ, Takei H, et al. A mechanism of drug resistance to tamoxifen in breast cancer. J Steroid Biochem Mol Biol 83: 75-83, 2003.
    • (2003) J Steroid Biochem Mol Biol , vol.83 , pp. 75-83
    • Schafer, J.M.1    Bentrem, D.J.2    Takei, H.3
  • 32
    • 18044368633 scopus 로고    scopus 로고
    • Genomic changes identified by comparative genomic hybridisation in docetaxel-resistant breast cancer cell lines
    • McDonald SL, Stevenson DA, Moir SE, et al. Genomic changes identified by comparative genomic hybridisation in docetaxel-resistant breast cancer cell lines. Eur J Cancer 41: 1086-94, 2005.
    • (2005) Eur J Cancer , vol.41 , pp. 1086-1094
    • McDonald, S.L.1    Stevenson, D.A.2    Moir, S.E.3
  • 33
    • 33746455616 scopus 로고    scopus 로고
    • Chemopreventive efficacy of all-trans-retinoic acid in biodegradable microspheres against epithelial cancers: Results in a 4-nitroquinoline 1-oxide-induced oral carcinogenesis model
    • Choi Y, Kim SY, Park K, et al. Chemopreventive efficacy of all-trans-retinoic acid in biodegradable microspheres against epithelial cancers: Results in a 4-nitroquinoline 1-oxide-induced oral carcinogenesis model. Int J Pharm 320: 45-52, 2006.
    • (2006) Int J Pharm , vol.320 , pp. 45-52
    • Choi, Y.1    Kim, S.Y.2    Park, K.3
  • 35
    • 0000216613 scopus 로고    scopus 로고
    • Chemotherapeutic synergism, potentiation and antagonism
    • Dulbecco R, editor., 2nd edn. San Diego, Academic Press
    • Chou T-C, Rideout D, Chou JH, Bertino JR. Chemotherapeutic synergism, potentiation and antagonism. In: Dulbecco R, editor. Encyclopedia of human biology (vol 2), 2nd edn. San Diego, Academic Press. 1997, pp 675-83.
    • (1997) Encyclopedia of human biology , vol.2 , pp. 675-683
    • Chou, T.-C.1    Rideout, D.2    Chou, J.H.3    Bertino, J.R.4
  • 36
    • 33750293878 scopus 로고    scopus 로고
    • Randomized study of paclitaxel and tamoxifen deposition into human brain tumors: Implications for the treatment of metastatic brain tumors
    • Fine RL, Chen J, Balmaceda C, et al. Randomized study of paclitaxel and tamoxifen deposition into human brain tumors: Implications for the treatment of metastatic brain tumors. Clin Cancer Res 12: 5770-6, 2006.
    • (2006) Clin Cancer Res , vol.12 , pp. 5770-5776
    • Fine, R.L.1    Chen, J.2    Balmaceda, C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.